Biotechnology Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune Why Alpine Immune Sciences Stock Is Trading Higher Today? – Alpine Immune Sciences (NASDAQ:ALPN), Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Vertex Pharmaceuticals’ Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Why Is Vertex Pharmaceuticals Stock Sliding Today? – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
